
Jan Christop L. Merene
Examiner (ID: 18719, Phone: (571)270-5032 , Office: P/3733 )
| Most Active Art Unit | 3733 |
| Art Unit(s) | 3733, 3773 |
| Total Applications | 1047 |
| Issued Applications | 660 |
| Pending Applications | 88 |
| Abandoned Applications | 313 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7711820
[patent_doc_number] => 20120004172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'SCREENING METHOD OF ANTI-LUNG OR ESOPHAGEAL CANCER COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/125549
[patent_app_country] => US
[patent_app_date] => 2009-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 28262
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13125549
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/125549 | SCREENING METHOD OF ANTI-LUNG OR ESOPHAGEAL CANCER COMPOUNDS | Aug 23, 2009 | Abandoned |
Array
(
[id] => 7586388
[patent_doc_number] => 20110280898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'INHBB EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/059617
[patent_app_country] => US
[patent_app_date] => 2009-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12875
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20110280898.pdf
[firstpage_image] =>[orig_patent_app_number] => 13059617
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/059617 | INHBB EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME | Aug 13, 2009 | Abandoned |
Array
(
[id] => 6622995
[patent_doc_number] => 20100003722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'PRODUCTION AND PURIFICATION OF IL-29'
[patent_app_type] => utility
[patent_app_number] => 12/537935
[patent_app_country] => US
[patent_app_date] => 2009-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36757
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20100003722.pdf
[firstpage_image] =>[orig_patent_app_number] => 12537935
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/537935 | Production and purification of IL-29 | Aug 6, 2009 | Issued |
Array
(
[id] => 8220799
[patent_doc_number] => 20120135002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-31
[patent_title] => 'Compounds and Methods for the Treatment of Cancer'
[patent_app_type] => utility
[patent_app_number] => 13/383847
[patent_app_country] => US
[patent_app_date] => 2009-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7055
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13383847
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/383847 | Compounds and Methods for the Treatment of Cancer | Jul 15, 2009 | Abandoned |
Array
(
[id] => 6351816
[patent_doc_number] => 20100021950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'SCREENING METHOD FOR ANTI-DIABETIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/502674
[patent_app_country] => US
[patent_app_date] => 2009-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 21408
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20100021950.pdf
[firstpage_image] =>[orig_patent_app_number] => 12502674
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/502674 | SCREENING METHOD FOR ANTI-DIABETIC COMPOUNDS | Jul 13, 2009 | Abandoned |
Array
(
[id] => 8066197
[patent_doc_number] => 20110243923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'ORGANIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/133464
[patent_app_country] => US
[patent_app_date] => 2009-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 21463
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0243/20110243923.pdf
[firstpage_image] =>[orig_patent_app_number] => 13133464
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/133464 | Methods of identifying a modulator that inhibits the binding between Epstein-Barr virus induced receptor 2 and cholesterol derived ligands | Jul 11, 2009 | Issued |
Array
(
[id] => 4523850
[patent_doc_number] => 07951776
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-31
[patent_title] => 'Methods for treatment of type 1 diabetes'
[patent_app_type] => utility
[patent_app_number] => 12/496180
[patent_app_country] => US
[patent_app_date] => 2009-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 54617
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/951/07951776.pdf
[firstpage_image] =>[orig_patent_app_number] => 12496180
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/496180 | Methods for treatment of type 1 diabetes | Jun 30, 2009 | Issued |
Array
(
[id] => 6162741
[patent_doc_number] => 20110160081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => ' FUNCTIONAL COMPLEMENTATION ASSAY FOR DEFINED GPCR OLIGOMERS'
[patent_app_type] => utility
[patent_app_number] => 13/000613
[patent_app_country] => US
[patent_app_date] => 2009-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 23507
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20110160081.pdf
[firstpage_image] =>[orig_patent_app_number] => 13000613
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/000613 | FUNCTIONAL COMPLEMENTATION ASSAY FOR DEFINED GPCR OLIGOMERS | Jun 30, 2009 | Abandoned |
Array
(
[id] => 5943494
[patent_doc_number] => 20110104114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'Polysaccharide-Protein Conjugates Reversibly Coupled Via Imine Bonds'
[patent_app_type] => utility
[patent_app_number] => 12/999076
[patent_app_country] => US
[patent_app_date] => 2009-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 20915
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20110104114.pdf
[firstpage_image] =>[orig_patent_app_number] => 12999076
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/999076 | Polysaccharide-protein conjugates reversibly coupled via imine bonds | Jun 25, 2009 | Issued |
Array
(
[id] => 6348579
[patent_doc_number] => 20100021467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-28
[patent_title] => 'METHOD OF DETECTING A CANCER CELL BY ABERRANT EXPRESSION OF A HUMAN K+ ION CHANNEL'
[patent_app_type] => utility
[patent_app_number] => 12/480913
[patent_app_country] => US
[patent_app_date] => 2009-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 16181
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20100021467.pdf
[firstpage_image] =>[orig_patent_app_number] => 12480913
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/480913 | METHOD OF DETECTING A CANCER CELL BY ABERRANT EXPRESSION OF A HUMAN K+ ION CHANNEL | Jun 8, 2009 | Abandoned |
Array
(
[id] => 6329400
[patent_doc_number] => 20100197895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'ANTIBODIES TO HUMAN TUMOR NECROSIS FACTOR RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 12/474428
[patent_app_country] => US
[patent_app_date] => 2009-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 55075
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20100197895.pdf
[firstpage_image] =>[orig_patent_app_number] => 12474428
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/474428 | ANTIBODIES TO HUMAN TUMOR NECROSIS FACTOR RECEPTOR | May 28, 2009 | Abandoned |
Array
(
[id] => 5373710
[patent_doc_number] => 20090311271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'Methods and Compositions for Selective Inhibition of Ligand Binding to the Lectin-Like Receptor for Oxidized Low Density Lipoprotein (LOX-1)'
[patent_app_type] => utility
[patent_app_number] => 12/473812
[patent_app_country] => US
[patent_app_date] => 2009-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 33453
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20090311271.pdf
[firstpage_image] =>[orig_patent_app_number] => 12473812
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/473812 | Methods and Compositions for Selective Inhibition of Ligand Binding to the Lectin-Like Receptor for Oxidized Low Density Lipoprotein (LOX-1) | May 27, 2009 | Abandoned |
Array
(
[id] => 7650858
[patent_doc_number] => 20110300127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'DRUG-CONTAINING COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 12/994707
[patent_app_country] => US
[patent_app_date] => 2009-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4979
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20110300127.pdf
[firstpage_image] =>[orig_patent_app_number] => 12994707
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/994707 | DRUG-CONTAINING COMPOSITION | May 26, 2009 | Abandoned |
Array
(
[id] => 7573086
[patent_doc_number] => 20110268742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'PCTP MODULATORS IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA'
[patent_app_type] => utility
[patent_app_number] => 12/991093
[patent_app_country] => US
[patent_app_date] => 2009-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5449
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0268/20110268742.pdf
[firstpage_image] =>[orig_patent_app_number] => 12991093
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/991093 | PCTP MODULATORS IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA | May 6, 2009 | Abandoned |
Array
(
[id] => 5485749
[patent_doc_number] => 20090275514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'USE OF CALMODULIN KINASE II INHIBITORS TO TREAT OR PREVENT HEART MUSCLE INFLAMMATION'
[patent_app_type] => utility
[patent_app_number] => 12/433265
[patent_app_country] => US
[patent_app_date] => 2009-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18818
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275514.pdf
[firstpage_image] =>[orig_patent_app_number] => 12433265
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/433265 | USE OF CALMODULIN KINASE II INHIBITORS TO TREAT OR PREVENT HEART MUSCLE INFLAMMATION | Apr 29, 2009 | Abandoned |
Array
(
[id] => 5385792
[patent_doc_number] => 20090227037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'NOVEL SCREENING METHOD'
[patent_app_type] => utility
[patent_app_number] => 12/428877
[patent_app_country] => US
[patent_app_date] => 2009-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 44760
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20090227037.pdf
[firstpage_image] =>[orig_patent_app_number] => 12428877
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/428877 | Screening method for binding property or signal transduction alterations | Apr 22, 2009 | Issued |
Array
(
[id] => 5385191
[patent_doc_number] => 20090226436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'Novel receptors'
[patent_app_type] => utility
[patent_app_number] => 12/384910
[patent_app_country] => US
[patent_app_date] => 2009-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 24269
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20090226436.pdf
[firstpage_image] =>[orig_patent_app_number] => 12384910
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/384910 | Novel receptors | Apr 8, 2009 | Abandoned |
Array
(
[id] => 5527204
[patent_doc_number] => 20090197281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'METHODS FOR DIAGNOSIS AND TREATMENT OF CHRONIC IMMUNE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/409367
[patent_app_country] => US
[patent_app_date] => 2009-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14892
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20090197281.pdf
[firstpage_image] =>[orig_patent_app_number] => 12409367
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/409367 | METHODS FOR DIAGNOSIS AND TREATMENT OF CHRONIC IMMUNE DISEASES | Mar 22, 2009 | Abandoned |
Array
(
[id] => 9620697
[patent_doc_number] => 08790869
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-29
[patent_title] => 'Renal cell carcinoma biomarkers'
[patent_app_type] => utility
[patent_app_number] => 13/257580
[patent_app_country] => US
[patent_app_date] => 2009-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 36091
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 415
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13257580
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/257580 | Renal cell carcinoma biomarkers | Mar 19, 2009 | Issued |
Array
(
[id] => 6137161
[patent_doc_number] => 20110009497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'DRUG-CONTAINING COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 12/933631
[patent_app_country] => US
[patent_app_date] => 2009-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5665
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20110009497.pdf
[firstpage_image] =>[orig_patent_app_number] => 12933631
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/933631 | DRUG-CONTAINING COMPOSITION | Mar 17, 2009 | Abandoned |